Last reviewed · How we verify
NCT04941118
Myofascial Pain Syndrome and Dextrose Prolotherapy
Phase 4 trial testing Injection of dextrose, local anesthetic and saline to the myofascial trigger point in Efficacy of Dextrose Prolotherapy in Myofascial Pain Syndrome in 60 participants. Status unknown.
30 December 2021
Quick facts
| Lead sponsor | Mustafa Kemal University |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 15 July 2021 |
| Primary completion | 30 December 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Injection of dextrose, local anesthetic and saline to the myofascial trigger point — full drug profile →
- Local anesthetic and saline injection to the myofascial trigger point — full drug profile →
Conditions studied
- Efficacy of Dextrose Prolotherapy in Myofascial Pain Syndrome — all drugs for Efficacy of Dextrose Prolotherapy in Myofascial Pain Syndrome →
Sponsor
Mustafa Kemal University
Who can join
Adults 20 to 50, female only, with Efficacy of Dextrose Prolotherapy in Myofascial Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Myofascial pain syndrome is characterized by the presence of hypersensitive points called trigger points that cause pain, tenderness, spasm, stiffness, limitation of movement, weakness, taut band within the muscle, and pain reflected by pressing in a muscle group or a single muscle. Prolotherapy is a regenerative treatment method in the treatment of chronic musculoskeletal pain, in which an irritating solution is injected, often hypertonic dextrose, into painful ligament and tendon attachments and adjacent joint spaces. In this study, it was aimed to examine the effect of prolotherapy application on pain, neck range of motion and neck disability in women with myofascial pain syndrome.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04941118
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Mustafa Kemal University trials
Trials by the same sponsor.
- NCT07307430 — Effect of Narrative Education on Glycemic Control in Adults With Type 2 Diabetes in Primary Care · NA · not yet recruiting
- NCT05969652 — Comparison of the Effectiveness Heavy Slow Resistance and Eccentric Training in Rotator Cuff Tendinopathy · NA · not yet recruiting
- NCT07328685 — Basic Body Awareness Therapy in Individuals With Migraine · NA · not yet recruiting
- NCT06715397 — Cross-Cultural Adaptation, Validity and Reliability of the Turkish Version of the Adolfsson-Björnsson Upper Extremity Ac · enrolling by invitation
- NCT07375576 — Outcomes of Pulpotomy and Root Canal Treatment in Teeth With Symptomatic Irreversible Pulpitis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04941118 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mustafa Kemal University
- Last refreshed: 21 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04941118.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing